Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Purple Biotech ADR PPBT

Healthcare
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PPBT)

Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting

GlobeNewswire 1 day ago

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024

GlobeNewswire March 28, 2024

Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology

GlobeNewswire March 14, 2024

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire March 5, 2024

Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024

GlobeNewswire February 27, 2024

Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial

GlobeNewswire February 13, 2024

Purple Biotech Reaches Recommended Phase 2 Dose for NT219

GlobeNewswire February 1, 2024

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

GlobeNewswire December 20, 2023

Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial

GlobeNewswire December 14, 2023
View More News ››

Opinion & Analysis (NDAQ:PPBT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PPBT)

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Fin

BREAKING NEWS: $PPBT Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial ResultsREHOVOT, Israel, March 05, 2024 (GLOBE...
whytestocks - March 5, 2024

KTOV To The Moon 🚀

Still holding since 47 cents. Waiting for KTOV and Merck Partnership.
TheGreatBull888 - June 30, 2020

new twitter

blitz from usual social media blitz. gl. follow me on twitter.
thedave2006 - May 10, 2020

it's a buy today for me

this one should do well this year,so glta.
coolfooldumbguy - March 14, 2019

this stock is for swing traders only

if you are a quick buck artist,while I am waiting for my solid stocks like ECA,etc.,it is like watching paint dry, I like to play with...
coolfooldumbguy - January 16, 2019

it's a sell today for me

 during the lunch hour,was able to sell it at $2.55 per share for a tidy profit of 137% gain on my money,so it was a great trade for...
coolfooldumbguy - January 15, 2019
View more Bullboard ››

Silver North Resources Ltd.

Silver North Resources Ltd.

Silver North Resources Ltd., formerly Alianza Minerals Ltd., is a Canada-based company, which is focused on silver ...
View More »